CRIS Current Research Information System

GIOVANNINI, CATIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.770
AS - Asia 2.761
EU - Europa 2.593
AF - Africa 205
SA - Sud America 174
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.509
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.728
CN - Cina 948
SG - Singapore 900
IT - Italia 796
GB - Regno Unito 429
VN - Vietnam 252
DE - Germania 240
SE - Svezia 240
HK - Hong Kong 194
NL - Olanda 158
IN - India 151
KR - Corea 142
BR - Brasile 124
CH - Svizzera 122
FR - Francia 105
RU - Federazione Russa 97
UA - Ucraina 86
IE - Irlanda 85
CI - Costa d'Avorio 59
FI - Finlandia 58
TG - Togo 49
JP - Giappone 41
BG - Bulgaria 38
ZA - Sudafrica 36
SC - Seychelles 33
ID - Indonesia 31
CA - Canada 30
EE - Estonia 30
JO - Giordania 27
EC - Ecuador 25
BE - Belgio 19
AT - Austria 15
ES - Italia 15
PK - Pakistan 15
AR - Argentina 12
NG - Nigeria 12
PL - Polonia 12
TR - Turchia 10
IL - Israele 9
MK - Macedonia 9
MX - Messico 9
CZ - Repubblica Ceca 8
HR - Croazia 7
DZ - Algeria 6
RO - Romania 6
MY - Malesia 5
SA - Arabia Saudita 5
AM - Armenia 4
AU - Australia 4
BD - Bangladesh 4
CO - Colombia 4
GR - Grecia 4
LB - Libano 4
PE - Perù 4
UZ - Uzbekistan 4
DK - Danimarca 3
IR - Iran 3
LT - Lituania 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
HU - Ungheria 2
KZ - Kazakistan 2
MA - Marocco 2
NP - Nepal 2
PH - Filippine 2
PY - Paraguay 2
SI - Slovenia 2
SN - Senegal 2
SR - Suriname 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AZ - Azerbaigian 1
CR - Costa Rica 1
CU - Cuba 1
EG - Egitto 1
HN - Honduras 1
KE - Kenya 1
KG - Kirghizistan 1
LI - Liechtenstein 1
LK - Sri Lanka 1
MD - Moldavia 1
ML - Mali 1
NO - Norvegia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 8.509
Salva come PNG Salva come JPEG
Città #
Singapore 600
Ashburn 400
Southend 355
Hefei 320
Bologna 259
Fairfield 247
Chandler 225
Hong Kong 191
Seoul 142
Santa Clara 129
Bern 119
Wilmington 119
Woodbridge 118
Houston 117
Beijing 103
Boardman 95
Seattle 89
Dublin 85
Princeton 81
Ann Arbor 77
Dallas 73
Cambridge 72
Milan 66
Abidjan 59
Jacksonville 52
Lomé 49
Los Angeles 42
Ho Chi Minh City 41
Helsinki 40
Sofia 38
Dong Ket 37
New York 37
Hanoi 36
Nanjing 34
Padova 34
Tokyo 33
Westminster 33
Florence 32
Bengaluru 30
Turin 28
Amman 27
Redondo Beach 26
Munich 25
Berlin 24
Buffalo 22
Jakarta 22
Amsterdam 21
Chicago 21
Jinan 21
San Diego 18
Changsha 17
London 17
Saint Petersburg 17
Hebei 16
Düsseldorf 14
Pune 14
Rome 14
Brussels 13
Frankfurt am Main 13
Jiaxing 13
Shenyang 13
Verona 13
Zhengzhou 13
Curitiba 12
São Paulo 12
Abeokuta 11
Brooklyn 11
Medford 11
Mülheim 11
Tongling 11
Edmonton 10
Guayaquil 10
Lauterbourg 10
Shanghai 10
Genoa 9
Guangzhou 9
Haikou 9
Lahore 9
Lappeenranta 9
Nanchang 9
Norwalk 9
Phoenix 9
Quito 9
Redmond 9
Bremen 8
Chennai 8
Da Nang 8
Dearborn 8
Falkenstein 8
Forlì 8
Mahé 8
Modena 8
Nuremberg 8
Orem 8
Reggio Emilia 8
Turku 8
Vienna 8
Yubileyny 8
Bühl 7
Council Bluffs 7
Totale 5.486
Salva come PNG Salva come JPEG
Nome #
In hepatocellular carcinoma miR-221 modulates sorafenib resistance through inhibition of caspase-3–mediated apoptosis 221
Aberrant Notch3 and Notch4 expression in human hepatocellular carcinoma. 215
Fast and real-time electrical transistor assay for quantifying SARS-CoV-2 neutralizing antibodies 202
Aflatoxin B1 DNA-Adducts in Hepatocellular Carcinoma from a Low Exposure Area 197
LncRNAs as novel players in hepatocellular carcinoma recurrence 193
MiR-494 induces metabolic changes through G6pc targeting and modulates sorafenib response in hepatocellular carcinoma 191
Metodo per valutare la capacità di un siero di neutralizzare un virus 189
MiR-30e-3p influences tumor phenotype through MDM2/TP53 axis and predicts sorafenib resistance in hepatocellular carcinoma 180
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. 177
Corrigendum: Vidatox 30 CH has tumor activating effect in hepatocellular carcinoma (Scientific Reports (2017) 7 (44685) DOI: 10.1038/srep44685) 173
CDKN1C/P57 Is Regulated by the Notch Target Gene Hes1 and Induces Senescence in Human Hepatocellular Carcinoma. 171
Fibrous hamartoma of corpus cavernosum: a rare cause of congenital penile curvature associated with erectile dysfunction. 170
Venom from Cuban Blue Scorpion has tumor activating effect in hepatocellular carcinoma 170
Synthetic torpor triggers a regulated mechanism in the rat brain, favoring the reversibility of Tau protein hyperphosphorylation 169
Determinazione della telomerasi nei tumori mammari della cagna: due metodi a confronto 168
IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland 163
Molecular and proteomic insight into Notch1 characterization in hepatocellular carcinoma 162
Early CTLA4 increase in CD45+ blood cells: an emerging biomarker of atezolizumab–bevacizumab resistance and worse survival in advanced hepatocarcinoma 160
MicroRNAs at the Crossroad between Immunoediting and Oncogenic Drivers in Hepatocellular Carcinoma 159
The epigenetically regulated miR-494 associates with stem-cell phenotype and induces sorafenib resistance in hepatocellular carcinoma 155
Circulating CD8 lymphocytes predict response to atezolizumab–bevacizumab in hepatocellular carcinoma 154
MiR-199-3p replacement affects E-cadherin expression through Notch1 targeting in hepatocellular carcinoma 154
F.N.27 NOTCH SIGNALLING CONTROLS PROLIFERATION AND SENESCENCE OF HUMAN HEPATOCELLULAR CARCINOMA 153
Neuroendocrine carcinoma of the urinary bladder: case report and review of the literature. 152
CARCINOMA COMPLETAMENTE NEUROENDOCRINO DELLA VESCICA IN GIOVANE PAZIENTE DI 37 ANNI: CASO CLINICO 151
Direct antiviral treatments for hepatitis c virus have off-target effects of oncologic relevance in hepatocellular carcinoma 150
Tacripyrimidines, the first tacrine-dihydropyrimidine hybrids, as multi-target-directed ligands for Alzheimer's disease 149
Molecules Present in Plant Essential Oils for Prevention and Treatment of Colorectal Cancer (CRC) 147
Targeting notch3 in hepatocellular carcinoma: Molecular mechanisms and therapeutic perspectives 143
Noncoding RNAs in Hepatocellular Carcinoma: Potential Applications in Combined Therapeutic Strategies and Promising Candidates of Treatment Response 142
Animal Models of Hepatocellular Carcinoma: Current Applications in Clinical Research 141
Organic Electrochemical Transistor (OECT) for Real Time, Electrical quantification of SARS CoV 2 neutralizing antibodies 141
Pharmaceutical composition and pharmaceutical kit for the treatment oh hepatocellular carcinoma 140
GADD45alpha expression in cirrhosis and hepatocellular carcinoma. Relationship with DNA-repair and proliferation. 140
Human hepatocellular carcinoma expresses specific PCNA isoforms: an in vivo and in vitro evaluation. 140
MiR-122/Cyclin G1 Interaction Modulates p53 Activity and Affects Doxorubicin Sensitivity of Human Hepatocarcinoma Cells. 139
Hepatic cancer stem cells: Molecular mechanisms, therapeutic implications, and circulating biomarkers 136
Organic Electrochemical Transistors as Versatile Tool for Real-Time and Automatized Viral Cytopathic Effect Evaluation 131
Apoptosis-related gene expression in benign prostatic hyperplasia and prostate carcinoma. Anticancer Res. 2006 May-Jun;26(3A):1849-54. 126
Selective ablation of Notch3 in HCC enhances doxorubicin's death promoting effect by a p53 dependent mechanism. 126
MicroRNAs in Animal Models of HCC 126
MiR-221 controls CDKN1C/p57 and CDKN1B/p27 expression in human hepatocellular carcinoma. 125
MiR-22/GLUT1 Axis Induces Metabolic Reprogramming and Sorafenib Resistance in Hepatocellular Carcinoma 121
Elucidating the Molecular Basis of Sorafenib Resistance in HCC: Current Findings and Future Directions 120
Notch Signaling and PD-1/PD-L1 Interaction in Hepatocellular Carcinoma: Potentialities of Combined Therapies 119
T.N.28 P53 IS REGULATED BY NOTCH3 SIGNALLING VIA MDM2 IN HEPATOCELLULAR CARCINOMA 116
Suppression of p53 by Notch3 is mediated by Cyclin G1 and sustained by MDM2 and miR-221 axis in hepatocellular carcinoma. 114
Notch3 inhibition enhances sorafenib cytotoxic efficacy by promoting GSK3b phosphorylation and p21 down-regulation in hepatocellular carcinoma. 113
Multifaceted Aspects of Dysfunctional Myelopoiesis in Cancer and Therapeutic Perspectives with Focus on HCC 105
OECTs for in-vitro, real-time impedance monitoring: from single cell sensing to tissue integrity 104
p66Shc/Notch-3 interplay controls self renewal and hypoxia survival inhuman stem/progenitor cells of the mammary gland expanded in vitro as mammo-spheres. 103
Brivanib in combination with Notch3 silencing shows potent activity in tumour models 102
Notch3 intracellular domain accumulates in HepG2 cell line. 97
Checkpoint effectors CDKN1A and Gadd45 correlate with oxidative DNA damage in human prostate carcinoma. 97
Expression of Fli-1 leads to increased notch activity through overexpression of fringe in colorectal cancer (CRC). 91
MicroRNAs as Modulators of Tumor Metabolism, Microenvironment, and Immune Response in Hepatocellular Carcinoma 85
Low-Baseline PD1+ Granulocytes Predict Responses to Atezolizumab–Bevacizumab in Hepatocellular Carcinoma 80
Notch signaling regulation in HCC: From hepatitis virus to non‐coding rnas 78
PEDOT:PSS OECTs as versatile devices for real-time monitoring of cytotoxicity and viral infection 77
Characterization of small nucleolar RNA retaining transcripts in human normal and cancer cells 74
Corrigendum: Synthetic torpor triggers a regulated mechanism in the rat brain, favoring the reversibility of Tau protein hyperphosphorylation (Frontiers in Physiology, (2023), 14, (1129278), 10.3389/fphys.2023.1129278) 59
PEDOT:PSS OECTs as versatile devices for real-time monitoring cytotoxicity and viral infection 57
PEDOT:PSS OECTs as versatile devices for monitoring cytotoxicity and viral infection in real-time 50
CXCL3 is a target of miR-30e-3p and predicts tumor escape in sorafenib-treated HCC patients. 19
Gut microbiome alterations and lenvatinib resistance in hepatocellular carcinoma: the role of Akkermansia muciniphila postbiotics in treatment enhancement 14
Towards precision medicine: a preliminary collection of patient-derived organoids for the screening of personalised therapies in hepatocellular carcinoma 9
The tumour suppressor miR-22 induces metabolic reprogramming through GLUT1 targeting and represents a possible biomarker of Sorafenib response in Hepatocellular Carcinoma 5
MiR-30e-3p plays a dual role in hepatocellular carcinoma and predicts tumour escape to sorafenib Treatment 3
MiR-22 downregulation activates HIF-1A pathway and induces tumour progression, metabolic reprogramming and sorafenib resistance in hepatocellular carcinoma 2
MiR-494 induces metabolic reprogramming through G6pc targeting and modulates sorafenib response in hepatocellular carcinoma 2
miR-30e-3p/CXCL3 axis predicts early tumor escape in sorafenib-treated hepatocellular carcinoma patients. 1
Totale 8.708
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.384
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.384
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021402 0 0 0 0 0 38 32 43 67 50 32 140
2021/2022910 73 35 63 84 69 44 16 79 37 81 211 118
2022/20231.201 111 135 83 132 68 100 22 65 185 29 94 177
2023/2024508 38 61 22 48 31 96 31 46 30 44 26 35
2024/20251.832 86 220 168 105 191 72 140 69 71 181 150 379
2025/20262.400 447 500 425 380 425 223 0 0 0 0 0 0
Totale 8.708